News Focus
News Focus
icon url

jesster64

06/30/25 1:14 PM

#773535 RE: Slave1 #773533

Thank You Slave1, I enjoy your posts and find them the most useful out of everyone here.
Some members seem to be posting about SOC more frequently. I just want approval and then take it from there. Approval should open the floodgates in SP, interest, and possible combo alternatives. Unfortunately, I have bills to pay so have to sell a number of shares each month. When posters keep moving the approval date expectation down the road, I get nervous.
I'm hoping that the delay is due to something big, possible SOC or good for all tumors. But I will be doing summersaults for any approval. I might even do a headstand for any good news.
icon url

Galzus Research

06/30/25 1:28 PM

#773538 RE: Slave1 #773533

Kite Pharma went public in 2014, got an FDA approval in mid-2017, and got bought almost immediately after.

The idea that big pharma wasn't watching autologous cell therapies with interest a decade ago is some wild revisionism.
icon url

Doc logic

06/30/25 2:40 PM

#773555 RE: Slave1 #773533

Slave1,

That is the fastest that could be achieved without big money or big pharma help and still remain independently controlled by existing shareholders. Where others would have fallen short, Linda found a way in spite of the added pressure of deliberate and illegal manipulation of share price which created even more dilution. Those desiring a cheap buyout or fine for their part in price suppression and development delays will find out the hard way that most shares are being held onto very tightly until the full intrinsic value is unlocked. Best wishes.